Literature DB >> 3428292

Complications following oral administration of exchange resins in extremely low-birth-weight infants.

A Ohlsson1, M Hosking.   

Abstract

Complications of the oral use of sodium polystyrene sulfonate and calcium polystyrene sulfonate are reported in five extremely low-birth-weight infants in which exchange resins were used to treat hyperkalemia. Radio opaque masses outlining the stomach were seen in all infants and could be palpated in the left upper quadrant of the abdomen. In two infants, at autopsy the palpable mass could be identified as a solid chalk-like concretion outlining the stomach. X-ray diffraction studies identified the material as Brushite. Administration of exchange resins by the gastric route should be avoided in the treatment of hyperkalemia in critically sick, extremely low-birth-weight infants.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3428292     DOI: 10.1007/BF02467356

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

Review 1.  Acute renal failure in the neonate.

Authors:  R Jain
Journal:  Pediatr Clin North Am       Date:  1977-08       Impact factor: 3.278

Review 2.  The critically ill child: acute renal failure.

Authors:  R S Dobrin; C D Larsen; M A Holliday
Journal:  Pediatrics       Date:  1971-08       Impact factor: 7.124

3.  Exchange transfusion using washed red blood cells reconstituted with fresh-frozen plasma for treatment of severe hyperkalemia in the neonate.

Authors:  E S Setzer; F Ahmed; R N Goldberg; R L Hellman; P Moscoso; P L Ferrer; T A Noto
Journal:  J Pediatr       Date:  1984-03       Impact factor: 4.406

4.  The emergency treatment of hyperkalemia.

Authors:  C L Kunis; J Lowenstein
Journal:  Med Clin North Am       Date:  1981-01       Impact factor: 5.456

5.  The microscopic appearance of a sodium-potassium exchange resin in histologic sections.

Authors:  R H Oi
Journal:  Am J Clin Pathol       Date:  1978-03       Impact factor: 2.493

6.  Mineralocorticoid unresponsiveness with severe neonatal hyponatremia and hyperkalemia.

Authors:  S Rosenberg; R C Franks; S Ulick
Journal:  J Clin Endocrinol Metab       Date:  1980-02       Impact factor: 5.958

7.  Kayexalate: a new cause of neonatal bowel opacification.

Authors:  S Sherman; A P Friedman; W E Berdon; J O Haller
Journal:  Radiology       Date:  1981-01       Impact factor: 11.105

  7 in total
  8 in total

1.  Giant intragastric sodium polystyrene sulfonate bezoar.

Authors:  Milian Croitoru; Aniela Shouval; Dimitry Chepurov; Yeshayahu Katz
Journal:  Kidney Int       Date:  2015-08       Impact factor: 10.612

2.  Treatment of infant formula with patiromer dose dependently decreases potassium concentration.

Authors:  Neil J Paloian; Barbara Bowman; Sharon M Bartosh
Journal:  Pediatr Nephrol       Date:  2019-04-08       Impact factor: 3.714

Review 3.  Interventions for non-oliguric hyperkalaemia in preterm neonates.

Authors:  Prakash Vemgal; Arne Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 4.  Bezoars: implicated drugs and avoidance strategies.

Authors:  K C Thompson; J P Iredale
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

5.  The use of histological techniques for the demonstration of ion exchange resins.

Authors:  A J Chaplin
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

6.  Potassium regulation in the neonate.

Authors:  Melvin Bonilla-Félix
Journal:  Pediatr Nephrol       Date:  2017-04-04       Impact factor: 3.714

7.  Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake.

Authors:  T E Bunchman; E G Wood; M H Schenck; K A Weaver; B L Klein; R E Lynch
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

8.  Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.

Authors:  Ji Lee; Brady S Moffett
Journal:  Pediatr Nephrol       Date:  2016-05-23       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.